Spain: Is this the end for IPT plans?
Spain's plans to consolidate its IPT assessment arrangements faced delays due to legal challenges, reflecting difficulties in changing infrastructure.
The intention was to introduce a formal economic analysis combined with clinical appraisals, similar to other established models. However, despite setbacks, there remains a shift towards emphasizing cost-effectiveness data and exploring innovative contracting, like risk-sharing outcome-based agreements, for medicines in Spain.
An extract from September’s EU/UK/Asia session of Verpora's webinar series exploring the latest trends and policies surrounding Global Innovative Contracting, in EU, UK and Asia regions.
Register here for future events
Disclaimer: This presentation is for discussion purposes only, and is not intended as legal or policy advice. This presentation is based on non-confidential intelligence. Views expressed by the speakers are personal opinions and should not be attributed to anyone else. No part of this webinar may be reproduced for commercial purposes without the express permission of Verpora.
